First Trust Advisors’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$352K Buy
+8,652
New +$371K ﹤0.01% 2497

Other funds holding URGN

First Trust Advisors's URGN Position: Q3 2026 in Review

First Trust Advisors opened a new position in UroGen Pharma (URGN) in Q3 2026: 8,652 shares worth $352K. The stake represents ﹤0.01% of the portfolio and ranks #2497 among its holdings.

221 funds tracked by Wall St. Rank hold URGN as of Q3 2026.

  • First Trust Advisors held 8,652 shares of UroGen Pharma worth $352K as of Q3 2026.
  • UroGen Pharma was a new First Trust Advisors position in Q3 2026.
  • UroGen Pharma made up ﹤0.01% of First Trust Advisors's portfolio in Q3 2026, its #2497 holding.
  • 221 funds tracked by Wall St. Rank held UroGen Pharma as of Q3 2026.

Based on First Trust Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.